{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:09:18Z","timestamp":1780387758804,"version":"3.54.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100020607","name":"Hitit University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100020607","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Chemotherapeutic agents used in cancer treatment cause damage to both oocytes and granulosa cells, resulting in follicle loss and consequently premature ovarian failure. In this study the animals were randomly assigned to three groups: control (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20096), chemotherapy (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20096), and stem cell treatment (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20096). Ovarian failure was induced in the chemotherapy and stem cell groups by intraperitoneal administration of cyclophosphamide (200\u00a0mg\/kg) on days 1 and 8. Ovarian stromal stem cells (OSSCs) were isolated from the ovaries of 4-week-old donor rats (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20092) using the explant culture method. On day 9, isolated stromal cells were transplanted bilaterally into the ovaries of rats in the stem cell group. Surface markers were analyzed by flow cytometry in OSSCs, and their adipogenic, osteogenic, and chondrogenic differentiation potentials were evaluated under appropriate in vitro conditions. The number of follicles and the morphological features of the ovarian tissue were histologically examined using hematoxylin and eosin (H&amp;E) staining. Caspase 3 expression in ovarian tissue was analyzed using TUNEL and immunohistochemistry methods. Flow cytometry analysis of isolated ovarian stromal cells showed that CD54, CD90 and CD45 surface markers were expressed, while CD29 was expressed at a lower level. These findings confirmed the ability of OSSCs to differentiate into adipogenic, osteogenic, and chondrogenic lineages in vitro. Follicle counting, TUNEL and immunohistochemical analysis showed that treatment with ovarian stromal stem cells significantly reduced the number of atretic follicles and increased the number of normally developing follicles in the ovaries of chemotherapy-treated rats. Our research demonstrates the therapeutic effects of (allogeneic) ovarian stromal stem cells present in their niche on ovarian toxicity induced by chemotherapy, suggesting an alternative treatment option for approaches aimed at preserving fertility.\n                  <\/jats:p>","DOI":"10.1007\/s43032-026-02114-7","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:04:07Z","timestamp":1777475047000},"page":"974-989","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic Effects of Stromal Stem Cells Derived from Ovarian Tissue in a Cyclophosphamide-Induced Rat Model of Ovarian Failure"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4733-6455","authenticated-orcid":false,"given":"Mehpare","family":"Akg\u00fcn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1992-7909","authenticated-orcid":false,"given":"Murat Serkant","family":"\u00dcnal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6816-1367","authenticated-orcid":false,"given":"Faruk","family":"Alt\u0131nba\u015fak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7187-1669","authenticated-orcid":false,"given":"Elif","family":"\u00d6nder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5609-9594","authenticated-orcid":false,"given":"Semih","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"2114_CR1","doi-asserted-by":"crossref","unstructured":"Liu RX, Zhang XY, Fan ZH, Wang YY, Yao GP, Wan X et al. Human amniotic mesenchymal stem cells improve the follicular microenvironment to recover ovarian function in premature ovarian failure mice. Stem Cell Res Ther. 2019;10(1). PubMed PMID: WOS:000501996900001. English.","DOI":"10.1186\/s13287-019-1315-9"},{"issue":"4","key":"2114_CR2","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/S0889-8529(05)70051-7","volume":"27","author":"SN Kalantaridou","year":"1998","unstructured":"Kalantaridou SN, Davis SR, Nelson LM. Premature ovarian failure. Endocrinol Metab Clin North Am. 1998;27(4):989\u20131006.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2114_CR3","unstructured":"Ross MH, Pawlina W. Histology: Lippincott Williams & Wilkins; 2006."},{"issue":"20","key":"2114_CR4","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.2217\/fon-2016-0176","volume":"12","author":"G Bedoschi","year":"2016","unstructured":"Bedoschi G, Navarro PA, Oktay K. Chemotherapy-induced damage to ovary: mechanisms and clinical impact. Future Oncol. 2016;12(20):2333\u201344.","journal-title":"Future Oncol"},{"issue":"5","key":"2114_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/humupd\/dms022","volume":"18","author":"S Morgan","year":"2012","unstructured":"Morgan S, Anderson R, Gourley C, Wallace W, Spears N. How do chemotherapeutic agents damage the ovary? Hum Reprod Update. 2012;18(5):525\u201335.","journal-title":"Hum Reprod Update"},{"issue":"5","key":"2114_CR6","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41419-023-05859-0","volume":"14","author":"S Zhang","year":"2023","unstructured":"Zhang S, Liu Q, Chang M, Pan Y, Yahaya BH, Liu Y, et al. Chemotherapy impairs ovarian function through excessive ROS-induced ferroptosis. Cell Death Dis. 2023;14(5):340.","journal-title":"Cell Death Dis"},{"key":"2114_CR7","doi-asserted-by":"publisher","first-page":"100435","DOI":"10.1016\/j.coemr.2023.100435","volume":"28","author":"E Kapoor","year":"2023","unstructured":"Kapoor E. Premature ovarian insufficiency. Curr Opin Endocr metabolic Res. 2023;28:100435.","journal-title":"Curr Opin Endocr metabolic Res"},{"issue":"1","key":"2114_CR8","first-page":"496218","volume":"2013","author":"DM Patel","year":"2013","unstructured":"Patel DM, Shah J, Srivastava AS. Therapeutic potential of mesenchymal stem cells in regenerative medicine. Stem cells Int. 2013;2013(1):496218.","journal-title":"Stem cells Int"},{"issue":"17","key":"2114_CR9","doi-asserted-by":"publisher","first-page":"6487","DOI":"10.7150\/thno.102641","volume":"14","author":"Z Yuan","year":"2024","unstructured":"Yuan Z, Zhang Y, He X, Wang X, Wang X, Ren S, et al. Engineering mesenchymal stem cells for premature ovarian failure: Overcoming challenges and innovating therapeutic strategies. Theranostics. 2024;14(17):6487.","journal-title":"Theranostics"},{"key":"2114_CR10","doi-asserted-by":"publisher","first-page":"749822","DOI":"10.3389\/fcell.2021.749822","volume":"9","author":"J Wang","year":"2021","unstructured":"Wang J, Liu W, Yu D, Yang Z, Li S, Sun X. Research progress on the treatment of premature ovarian failure using mesenchymal stem cells: a literature review. Front Cell Dev Biology. 2021;9:749822.","journal-title":"Front Cell Dev Biology"},{"issue":"1","key":"2114_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.tjog.2018.11.010","volume":"58","author":"HE Besikcioglu","year":"2019","unstructured":"Besikcioglu HE, Sar\u0131bas GS, Ozogul C, Tiryaki M, Kilic S, P\u0131narl\u0131 FA, et al. Determination of the effects of bone marrow derived mesenchymal stem cells and ovarian stromal stem cells on follicular maturation in cyclophosphamide induced ovarian failure in rats. Taiwan J Obstet Gynecol. 2019;58(1):53\u20139.","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"3","key":"2114_CR12","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1530\/REP-19-0501","volume":"160","author":"HM Kinnear","year":"2020","unstructured":"Kinnear HM, Tomaszewski CE, Chang AL, Moravek MB, Xu M, Padmanabhan V, et al. The ovarian stroma as a new frontier. Reproduction. 2020;160(3):R25\u201339.","journal-title":"Reproduction"},{"key":"2114_CR13","unstructured":"\u00dcnal MS, \u00d6nder E, \u00c7oban H\u015e, \u00c7il N, Se\u00e7me M, Y\u0131ld\u0131r\u0131m G et al. Ovaryum Dokusunun Eksplant K\u00fclt\u00fcr\u00fc. Van T\u0131p Dergisi. 2022."},{"issue":"5","key":"2114_CR14","doi-asserted-by":"publisher","first-page":"e13100","DOI":"10.1111\/ahe.13100","volume":"53","author":"F Altinbasak","year":"2024","unstructured":"Altinbasak F, Unal MS, Tan S, Yildirim G. The effects of testicular stromal stem cells on surgically injured testicular tissue in rats. Anat Histol Embryol. 2024;53(5):e13100.","journal-title":"Anat Histol Embryol"},{"key":"2114_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2164-15-910","volume":"15","author":"B Roson-Burgo","year":"2014","unstructured":"Roson-Burgo B, Sanchez-Guijo F, Del Ca\u00f1izo C, De Las Rivas J. Transcriptomic portrait of human mesenchymal stromal\/stem cells isolated from bone marrow and placenta. BMC Genomics. 2014;15:1\u201318.","journal-title":"BMC Genomics"},{"key":"2114_CR16","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jsbmb.2013.06.005","volume":"138","author":"M Qiu","year":"2013","unstructured":"Qiu M, Quan F, Han C, Wu B, Liu J, Yang Z, et al. Effects of granulosa cells on steroidogenesis, proliferation and apoptosis of stromal cells and theca cells derived from the goat ovary. J Steroid Biochem Mol Biol. 2013;138:325\u201333.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"2114_CR17","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/rda.12256","volume":"49","author":"M Qiu","year":"2014","unstructured":"Qiu M, Liu J, Han C, Wu B, Yang Z, Su F, et al. The influence of ovarian stromal\/theca cells during in vitro culture on steroidogenesis, proliferation and apoptosis of granulosa cells derived from the goat ovary. Reprod Domest Anim. 2014;49(1):170\u20136.","journal-title":"Reprod Domest Anim"},{"key":"2114_CR18","unstructured":"Unal MS, Secme M. Does the ovarian surface epithelium differentiate into primordial follicle and primary follicle precursor structures? Cukurova Med J. 2022."},{"key":"2114_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-015-0516-y","volume":"13","author":"D Lai","year":"2015","unstructured":"Lai D, Wang F, Yao X, Zhang Q, Wu X, Xiang C. Human endometrial mesenchymal stem cells restore ovarian function through improving the renewal of germline stem cells in a mouse model of premature ovarian failure. J translational Med. 2015;13:1\u201313.","journal-title":"J translational Med"},{"key":"2114_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-018-1008-9","volume":"9","author":"Y He","year":"2018","unstructured":"He Y, Chen D, Yang L, Hou Q, Ma H, Xu X. The therapeutic potential of bone marrow mesenchymal stem cells in premature ovarian failure. Stem Cell Res Ther. 2018;9:1\u20137.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"2114_CR21","doi-asserted-by":"publisher","first-page":"23120","DOI":"10.1038\/srep23120","volume":"6","author":"G-Y Xiao","year":"2016","unstructured":"Xiao G-Y, Cheng C-C, Chiang Y-S, Cheng WT-K, Liu I-H, Wu S-C. Exosomal miR-10a derived from amniotic fluid stem cells preserves ovarian follicles after chemotherapy. Sci Rep. 2016;6(1):23120.","journal-title":"Sci Rep"},{"key":"2114_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-020-01904-3","volume":"11","author":"L Cui","year":"2020","unstructured":"Cui L, Bao H, Liu Z, Man X, Liu H, Hou Y, et al. hUMSCs regulate the differentiation of ovarian stromal cells via TGF-\u03b2 1\/Smad3 signaling pathway to inhibit ovarian fibrosis to repair ovarian function in POI rats. Stem Cell Res Ther. 2020;11:1\u201312.","journal-title":"Stem Cell Res Ther"},{"key":"2114_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5505\/vmj.2025.07088","volume":"32","author":"MSYH \u00dcnal","year":"2025","unstructured":"\u00dcnal MSYH, Kabuk\u00e7u C, Uysal A, Duran A, Co\u011fuplugil A, et al. Heterotopic ovary transplantation containing periovarian adipose tissue. Van Med J. 2025;32:3.","journal-title":"Van Med J"},{"issue":"1","key":"2114_CR24","first-page":"6539294","volume":"2019","author":"Q Zheng","year":"2019","unstructured":"Zheng Q, Fu X, Jiang J, Zhang N, Zou L, Wang W, et al. Umbilical cord mesenchymal stem cell transplantation prevents chemotherapy-induced ovarian failure via the NGF\/TrkA pathway in rats. Biomed Res Int. 2019;2019(1):6539294.","journal-title":"Biomed Res Int"},{"key":"2114_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-018-0781-9","volume":"9","author":"C Ding","year":"2018","unstructured":"Ding C, Zou Q, Wang F, Wu H, Chen R, Lv J, et al. Human amniotic mesenchymal stem cells improve ovarian function in natural aging through secreting hepatocyte growth factor and epidermal growth factor. Stem Cell Res Ther. 2018;9:1\u201311.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"2114_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/labinvest.2012.167","volume":"93","author":"Y Takehara","year":"2013","unstructured":"Takehara Y, Yabuuchi A, Ezoe K, Kuroda T, Yamadera R, Sano C, et al. The restorative effects of adipose-derived mesenchymal stem cells on damaged ovarian function. Lab Invest. 2013;93(2):181\u201393.","journal-title":"Lab Invest"},{"key":"2114_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-019-1327-5","volume":"10","author":"Z Yang","year":"2019","unstructured":"Yang Z, Du X, Wang C, Zhang J, Liu C, Li Y, et al. Therapeutic effects of human umbilical cord mesenchymal stem cell-derived microvesicles on premature ovarian insufficiency in mice. Stem Cell Res Ther. 2019;10:1\u201312.","journal-title":"Stem Cell Res Ther"},{"key":"2114_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-019-1315-9","volume":"10","author":"R Liu","year":"2019","unstructured":"Liu R, Zhang X, Fan Z, Wang Y, Yao G, Wan X, et al. Human amniotic mesenchymal stem cells improve the follicular microenvironment to recover ovarian function in premature ovarian failure mice. Stem Cell Res Ther. 2019;10:1\u201314.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"2114_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/1933719117699705","volume":"25","author":"SA Mohamed","year":"2018","unstructured":"Mohamed SA, Shalaby SM, Abdelaziz M, Brakta S, Hill WD, Ismail N, et al. Human mesenchymal stem cells partially reverse infertility in chemotherapy-induced ovarian failure. Reproductive Sci. 2018;25(1):51\u201363.","journal-title":"Reproductive Sci"},{"key":"2114_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-017-0514-5","volume":"8","author":"J Li","year":"2017","unstructured":"Li J, Mao Q, He J, She H, Zhang Z, Yin C. Human umbilical cord mesenchymal stem cells improve the reserve function of perimenopausal ovary via a paracrine mechanism. Stem Cell Res Ther. 2017;8:1\u201311.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"2114_CR31","first-page":"2517514","volume":"2016","author":"D Song","year":"2016","unstructured":"Song D, Zhong Y, Qian C, Zou Q, Ou J, Shi Y, et al. Human umbilical cord mesenchymal stem cells therapy in cyclophosphamide-induced premature ovarian failure rat model. Biomed Res Int. 2016;2016(1):2517514.","journal-title":"Biomed Res Int"},{"issue":"1","key":"2114_CR32","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13287-018-0953-7","volume":"9","author":"B Huang","year":"2018","unstructured":"Huang B, Lu J, Ding C, Zou Q, Wang W, Li H. Exosomes derived from human adipose mesenchymal stem cells improve ovary function of premature ovarian insufficiency by targeting SMAD. Stem Cell Res Ther. 2018;9(1):216.","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"2114_CR33","doi-asserted-by":"publisher","first-page":"592","DOI":"10.7150\/ijms.4841","volume":"9","author":"T Liu","year":"2012","unstructured":"Liu T, Huang Y, Guo L, Cheng W, Zou G. CD44+\/CD105\u2009+\u2009human amniotic fluid mesenchymal stem cells survive and proliferate in the ovary long-term in a mouse model of chemotherapy-induced premature ovarian failure. Int J Med Sci. 2012;9(7):592.","journal-title":"Int J Med Sci"},{"key":"2114_CR34","doi-asserted-by":"crossref","unstructured":"Gorre N, Adhikari D, Lindkvist R, Br\u00e4nnstr\u00f6m M, Liu K, Shen Y. mTORC1 signaling in oocytes is dispensable for the survival of primordial follicles and for female fertility. PLoS ONE. 2014;9(10). PubMed PMID: WOS:000343674800047. English.","DOI":"10.1371\/journal.pone.0110491"},{"issue":"2","key":"2114_CR35","doi-asserted-by":"publisher","first-page":"249","DOI":"10.18229\/kocatepetip.849512","volume":"24","author":"G Kabasakal","year":"2023","unstructured":"Kabasakal G, Tural E, \u00dcnal MS. Deneysel Overyan Yetmezliklerde Mezenkimal K\u00f6k H\u00fccrelerin Ovaryum Dokusuna Etkisi. Kocatepe T\u0131p Dergisi. 2023;24(2):249\u201353.","journal-title":"Kocatepe T\u0131p Dergisi"},{"issue":"12","key":"2114_CR36","first-page":"5087","volume":"17","author":"AL Liu","year":"2016","unstructured":"Liu AL, Liao HQ, Li ZL, Liu J, Zhou CL, Guo ZF, et al. New insights into mTOR signal pathways in ovarian-related diseases: Polycystic ovary syndrome and ovarian cancer. Asian Pac J cancer prevention: APJCP. 2016;17(12):5087.","journal-title":"Asian Pac J cancer prevention: APJCP"},{"key":"2114_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1757-2215-5-38","volume":"5","author":"A Yaba","year":"2012","unstructured":"Yaba A, Demir N. The mechanism of mTOR (mammalian target of rapamycin) in a mouse model of polycystic ovary syndrome (PCOS). J ovarian Res. 2012;5:1\u201312.","journal-title":"J ovarian Res"},{"issue":"2","key":"2114_CR38","doi-asserted-by":"publisher","first-page":"e0117769","DOI":"10.1371\/journal.pone.0117769","volume":"10","author":"Y Cheng","year":"2015","unstructured":"Cheng Y, Kim J, Li XX, Hsueh AJ. Promotion of ovarian follicle growth following mTOR activation: synergistic effects of AKT stimulators. PLoS ONE. 2015;10(2):e0117769.","journal-title":"PLoS ONE"},{"issue":"5","key":"2114_CR39","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1080\/15384101.2014.995496","volume":"14","author":"X Sun","year":"2015","unstructured":"Sun X, Su Y, He Y, Zhang J, Liu W, Zhang H, et al. New strategy for in vitro activation of primordial follicles with mTOR and PI3K stimulators. Cell Cycle. 2015;14(5):721\u201331.","journal-title":"Cell Cycle"},{"issue":"12","key":"2114_CR40","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/mrd.22267","volume":"80","author":"Y Tong","year":"2013","unstructured":"Tong Y, Li F, Lu Y, Cao Y, Gao J, Liu J. Rapamycin-sensitive mTORC1 signaling is involved in physiological primordial follicle activation in mouse ovary. Mol Reprod Dev. 2013;80(12):1018\u201334.","journal-title":"Mol Reprod Dev"},{"key":"2114_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13048-017-0350-3","volume":"10","author":"L Zhou","year":"2017","unstructured":"Zhou L, Xie Y, Li S, Liang Y, Qiu Q, Lin H, et al. Rapamycin prevents cyclophosphamide-induced over-activation of primordial follicle pool through PI3K\/Akt\/mTOR signaling pathway in vivo. J ovarian Res. 2017;10:1\u201311.","journal-title":"J ovarian Res"},{"issue":"6","key":"2114_CR42","doi-asserted-by":"publisher","first-page":"118688","DOI":"10.1016\/j.bbamcr.2020.118688","volume":"1867","author":"A Boice","year":"2020","unstructured":"Boice A, Bouchier-Hayes L. Targeting apoptotic caspases in cancer. Biochim Biophys Acta (BBA)-Mol Cell Res. 2020;1867(6):118688.","journal-title":"Biochim Biophys Acta (BBA)-Mol Cell Res"},{"issue":"7","key":"2114_CR43","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s10495-022-01735-y","volume":"27","author":"S Kari","year":"2022","unstructured":"Kari S, Subramanian K, Altomonte IA, Murugesan A, Yli-Harja O, Kandhavelu M. Programmed cell death detection methods: a systematic review and a categorical comparison. Apoptosis. 2022;27(7):482\u2013508.","journal-title":"Apoptosis"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-026-02114-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-026-02114-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-026-02114-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:36:18Z","timestamp":1780385778000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-026-02114-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2114"],"URL":"https:\/\/doi.org\/10.1007\/s43032-026-02114-7","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Pamukkale University. Animal Experiments Ethics Committee as a research project with the number PAUHDEK-2020\/10 on 05.06.2020.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare that there are no conflicts of interest regarding the publication of this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}